Trial Profile

A phase III study of STP705 for the treatment of Squamous Cell Carcinoma in situ (isSCC)

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 02 Apr 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs STP 705 (Primary)
Indications Squamous cell cancer
Focus Registrational; Therapeutic Use
Sponsors Sirnaomics

Most Recent Events

28 Mar 2024 According to a Sirnaomics media release, the company expects to provide an update about Phase II/III study to serve as a pivotal trial to achieve alignment with the U.S. FDA in the second quarter of 2024.
21 Jun 2023 New trial record
19 Jun 2023 According to a Sirnaomics media release, based on encouraging Phase IIa and Phase IIb clinical results the U.S. Food and Drug Administration (FDA) in an End of Phase-2 meeting has given guidance to move forward in phase III trial.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com